New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

Edwards Lifesciences' EARLY TAVR trial results ... As we noted earlier this year, the Company's flagship transcatheter aortic valve replacement (TAVR) franchise slowed as compared to the ...

Wedgewood Partners highlighted stocks like Edwards Lifesciences Corporation ... the Company's flagship transcatheter aortic valve replacement (TAVR) franchise slowed as compared to the Company's ...

"Edwards Lifesciences Corporation (NYSE:EW) was a contributor to quarterly performance but only slightly impacted annual portfolio performance. As we noted earlier this year, the Company's flagship ...

WASHINGTON – During the fourth quarter of the Timberwolves’ 120-106 victory over the Wizards on Monday night, Anthony Edwards came to a realization — the Wizards weren’t putting double ...

Copyright 2025 The Associated Press. All Rights Reserved. Minnesota Timberwolves assistant coach Pablo Prigioni, left, gets in the way of guard Anthony Edwards after ...

Anthony Edwards is one of the highest paid players in the NBA, but his wallet is taking another hit. The league fined the Minnesota Timberwolves star $50,000 for what was described as "obscene ...

Medtech giants like Medtronic, Abbott, and Edwards Lifesciences captured ... its next-generation Avalus Ultra surgical aortic tissue valve in April of 2024, offering improved ease of use, long ...